Eli Lilly and (LLY) had the highest return in 1997 by a US stock in the Pharmaceuticals Industry, returning 93.2%.
| ASSET | YEAR | % RETURN |
|---|---|---|
Eli Lilly and (LLY) | 1997 | 93.18% |
Pfizer (PFE) | 1997 | 81.92% |
Bristol-Myers Squibb (BMY) | 1997 | 77.48% |
Nektar Therapeutics (NKTR) | 1997 | 71.9% |
Novo Nordisk A-S (NVO) | 1997 | 60.28% |
GlaxoSmithKline PLC ADR (GSK) | 1997 | 55.86% |
Novartis AG ADR (NVS) | 1997 | 52.78% |
Bausch Health Companies (BHC) | 1997 | 49.52% |
Perrigo (PRGO) | 1997 | 46.58% |
Merck (MRK) | 1997 | 35.65% |
Johnson & Johnson (JNJ) | 1997 | 33.96% |
Viatris (VTRS) | 1997 | 27.08% |
Assertio Therapeutics (ASRT) | 1997 | 6.25% |
Teva Pharma Industries Ltd ADR (TEVA) | 1997 | -4.71% |
SIGA Technologies (SIGA) | 1997 | -17.78% |
ALT5 Sigma (ALTS) | 1997 | -30.77% |